Hill calls out WNBA revenue structure
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Pirates complete sweep of AL-best Tigers on heels of getting swept by AL-worst White Sox
It's been a polarized week for the Pittsburgh Pirates since their return from the MLB All-Star break. The Pirates opened the second half of their regular-season schedule by getting swept by the Chicago White Sox, the worst team in the American League. They followed that up with a sweep of the Detroit Tigers, the team with the best record in the AL. [Join or create a Yahoo Fantasy Football league for the 2025 NFL season] The Pirates completed the three-game sweep of the Tigers on Wednesday with a 6-1 win. They also won, 8-5 on Tuesday and 3-0 on Monday, anchored by six shutout innings from Paul Skenes. Per Elias Sports Bureau, that makes the Pirates the first team since the 1980 San Diego Padres to get swept by the worst team and a league and sweep the best team in the league in back-to-back series past the midway point of the season. The third consecutive loss to Pittsburgh dropped the Tigers to 60-43, into a virtual tie with the Houston Astros (59-42) and Toronto Blue Jays (59-42) for the best record in the AL. Though the Astros and Blue Jays (.584) have a better winning percentage by a smidge than the the Tigers (.583) thanks to having played two fewer games each. The White Sox, meanwhile, remain the dregs of the AL at 36-66 (.354) So which Pirates are the real Pirates? Their record speaks for itself. Despite the sweep of the Tigers, the Pirates remain one of the worst teams in baseball and sit at the bottom of the NL Central with a 42-61 (.408) record. This is a team that's produced a 5-8 record for Skenes, a Cy Young contender with a 1.91 ERA and 0.91 WHIP. The sweep of the Tigers is a highlight of their season, but it's not a sign of anything larger for the Pirates.
Yahoo
8 minutes ago
- Yahoo
US EPA moves to approve dicamba weedkiller use on cotton, soybeans
By Leah Douglas and Tom Polansek WASHINGTON (Reuters) -The U.S. Environmental Protection Agency on Wednesday proposed approvals for three products containing the weedkiller dicamba, whose use was halted by a federal court in 2024, arguing it does not pose a significant human health or environmental risk. Cotton and soybean farmers had sprayed dicamba on crops that were genetically engineered to resist the herbicide, which controls tough weeds. Environmental groups have criticized the chemical because it can drift from where it is sprayed and damage neighboring plants. A 2024 U.S. District Court ruling found the EPA previously violated public input procedures in its approval of three dicamba products, and vacated the product registrations. As a result, farmers were unable to spray dicamba on crops this year. The EPA has received applications from Bayer AG, BASF and Syngenta for new approvals, the agency said in regulatory documents. Bayer, which sold the dicamba herbicide XtendiMax, said it was pleased the EPA opened a public comment period on its proposal to approve dicamba usage. "We are confident that low-volatility dicamba herbicides, when used according to the label, can be used safely and successfully on-target," Bayer said. BASF said it would work with regulators to ensure farmers can use dicamba. Syngenta did not immediately respond to a request for comment. An EPA review found no risk to human health from the products, but some risk to certain plants, it said in a release. To mitigate that risk, the agency is proposing restrictions on how much of the chemical can be applied and when, the release said. The top pesticides official at the EPA's Office of Chemical Safety and Pollution Prevention, Kyle Kunkler, previously worked as a lobbyist for the American Soybean Association, which has supported allowing farmers to spray dicamba on soybeans. The association said it was reviewing the EPA's proposal and that dicamba is a critical tool for farmers.
Yahoo
8 minutes ago
- Yahoo
MrBeast CEO and 'Beast Games' winner rally brand partners and rare disease support on Wall Street
NEW YORK (AP) — MrBeast's new CEO hit Wall Street Wednesday as YouTuber Jimmy Donaldson's media empire looks to develop long-term brand partnerships and, in turn, unlock more funding for its charitable content. Venture capitalist Jeff Housenbold took over MrBeast leadership last summer with a mandate to professionalize an ever-growing entertainment company. YouTube's most popular creator had reached record audience levels far outpacing its startup days, while vowing to reassess its internal culture amid multiple controversies. But, despite joining Nasdaq's closing bell ceremony on Wednesday, Housenbold said their strategic plan does not currently include a public offering — or any active funding rounds. 'Do I want to make banger content? Yeah. That's cool," Housenbold told The Associated Press. "But what can we do with that banger content? Generate profits, make a sustainable business that gives us greater ability to impact people's lives around the world.' 'We're marching quickly to profitability, so we don't have to raise additional capital,' he added. Instead, MrBeast is focused on securing multi-year exclusive advertising deals as opposed to single-video brand partnerships. With 416 million subscribers and legions of impressionable young fans, Housenbold argued that MrBeast is uniquely positioned to deliver more bang for companies' marketing bucks by pointing that 'firehouse of attention' at them. Along the way, Housenbold said he is encouraging Donaldson to tout the channel's charitable works — which often feature quantifiable stunts such as building wells, removing ocean plastic or covering cataract surgery costs. The company, in his view, 'can do good while doing well.' 'The more people who like us 'cause we do good, the more people watch our videos," he said. 'The more people watch our videos, the more we're able to drive in fees from our advertising partners... the more we can invest in more content to do more good in the world.' New projects such as the Amazon Prime reality show and a James Patterson novel from HarperCollins aim to diversify the genders and ages of his audience. Housenbold said that base has historically consisted mostly of 8-to-25-year-olds and men. But Housenbold acknowledged missteps in last year's production of 'Beast Games," which prompted allegations of 'unsafe' conditions from some contestants who said an unorganized set led to injuries, irregular food provision and lacking access to medication. While describing most of those reports as 'inaccurate,' Housenbold said they were 'better prepared' for the second season's recently wrapped shoot. 'Building sets for a 10-episode show is different than a 22-minute YouTube video," he said. "The scale, the size, the sophistication, the safety, the security, the cost effectiveness of doing that. We didn't staff up enough for Beast Games.' Ringing Nasdaq's closing bell Wednesday with Housenbold was the winner of the $10 million grand prize awarded in that inaugural 'Beast Games' season. Jeffrey Allen, the father of a child with creatine transporter deficiency, has promised to put some of his winnings toward existing treatments and research for a cure to the rare genetic disorder. He said the Association for Creatine Deficiencies, where he is a board member, added 1,000 new donors in the weeks following the final 'Beast Games' episodes' release. He hopes Wednesday's visit will draw more attention and money to all rare diseases. 'This is where companies that are bringing true change to the marketplace come to listen to other companies," Allen said. "So, there's no better place for a budding rare disease nonprofit to come and show, 'Hey we're trying to change the world, too.'' ___ Associated Press coverage of philanthropy and nonprofits receives support through the AP's collaboration with The Conversation US, with funding from Lilly Endowment Inc. The AP is solely responsible for this content. For all of AP's philanthropy coverage, visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
